I S Voruganti1, E Donovan1,2, C Walker-Dilks3, A Swaminath4,5. 1. Department of Radiation Oncology, University of Toronto, Toronto. 2. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto. 3. Program in Evidence-Based Care, McMaster University, Hamilton. 4. Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton. 5. Department of Oncology, McMaster University, Hamilton, ON.
Abstract
Background: Radiation-induced chest wall pain (cwp) and rib fracture (rf) are late adverse effects after stereotactic body radiation therapy (sbrt) for stage i non-small-cell lung cancer (nsclc); however, the literature about their incidence and risk factors shows variability. We performed a systematic review to determine the pooled incidence of cwp and rf in the relevant population. Methods: A literature search using the prisma (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines considered English publications in medline and embase from January 1996 to August 2017. Abstracts were screened, followed by full-text review and data extraction. Results: The database searches identified 547 records. Twenty-eight publications comprising 3892 patients met the inclusion criteria. Median reported ages and follow-up durations fell into the ranges 67-82 years and 12-84 months. Prescriptions fell into the range of 40-70 Gy in 3-10 fractions. Despite study heterogeneity, the pooled incidences of cwp and rf were estimated to be 8.94% and 5.27% respectively. Nineteen studies reported cwp grade: 58 of 308 patients (18.8%) experienced grades 3-4 cwp (no grade 5 events reported). Thirteen studies reported rf grade: grades 3-4 rf were observed in 9 of 113 patients (7.96%). A high chest wall V 30 was an important predictor of cwp and rf. Conclusions: In patients with stage i nsclc, rates of cwp and rf after sbrt are low; however, tumour location, accurate toxicity reporting, and dose-fractionation schemes might alter those rates. Prospective correlation with dosimetry and quality of life assessment will further improve the understanding of cwp and rf after sbrt. 2020 Multimed Inc.
Background: Radiation-induced chest wall pain (cwp) and rib fracture (rf) are late adverse effects after stereotactic body radiation therapy (sbrt) for stage i non-small-cell lung cancer (nsclc); however, the literature about their incidence and risk factors shows variability. We performed a systematic review to determine the pooled incidence of cwp and rf in the relevant population. Methods: A literature search using the prisma (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines considered English publications in medline and embase from January 1996 to August 2017. Abstracts were screened, followed by full-text review and data extraction. Results: The database searches identified 547 records. Twenty-eight publications comprising 3892 patients met the inclusion criteria. Median reported ages and follow-up durations fell into the ranges 67-82 years and 12-84 months. Prescriptions fell into the range of 40-70 Gy in 3-10 fractions. Despite study heterogeneity, the pooled incidences of cwp and rf were estimated to be 8.94% and 5.27% respectively. Nineteen studies reported cwp grade: 58 of 308 patients (18.8%) experienced grades 3-4 cwp (no grade 5 events reported). Thirteen studies reported rf grade: grades 3-4 rf were observed in 9 of 113 patients (7.96%). A high chest wall V 30 was an important predictor of cwp and rf. Conclusions: In patients with stage i nsclc, rates of cwp and rf after sbrt are low; however, tumour location, accurate toxicity reporting, and dose-fractionation schemes might alter those rates. Prospective correlation with dosimetry and quality of life assessment will further improve the understanding of cwp and rf after sbrt. 2020 Multimed Inc.
Authors: Anand Swaminath; Marcin Wierzbicki; Sameer Parpia; James R Wright; Theodoros K Tsakiridis; Gordon S Okawara; Vijayananda Kundapur; Alexis Bujold; Naseer Ahmed; Khalid Hirmiz; Elizabeth Kurien; Edith Filion; Zsolt Gabos; Sergio Faria; Alexander V Louie; Timothy Owen; Elaine Wai; Kevin Ramchandar; Elisa K Chan; Jim Julian; Kathryn Cline; Timothy J Whelan Journal: Clin Lung Cancer Date: 2016-10-03 Impact factor: 4.785
Authors: Noëlle C van der Voort van Zyp; Jean-Briac Prévost; Bronno van der Holt; Cora Braat; Robertus J van Klaveren; Peter M Pattynama; Peter C Levendag; Joost J Nuyttens Journal: Int J Radiat Oncol Biol Phys Date: 2009-10-26 Impact factor: 7.038
Authors: Joe Y Chang; Qiao-Qiao Li; Qing-Yong Xu; Pamela K Allen; Neal Rebueno; Daniel R Gomez; Peter Balter; Ritsuko Komaki; Reza Mehran; Stephen G Swisher; Jack A Roth Journal: Int J Radiat Oncol Biol Phys Date: 2014-04-01 Impact factor: 7.038
Authors: Mojgan Taremi; Andrew Hope; Patricia Lindsay; Max Dahele; Sharon Fung; Thomas G Purdie; David Jaffray; Laura Dawson; Andrea Bezjak Journal: Radiat Oncol Date: 2012-09-17 Impact factor: 3.481
Authors: Thibaud P Coroller; Raymond H Mak; John H Lewis; Elizabeth H Baldini; Aileen B Chen; Yolonda L Colson; Fred L Hacker; Gretchen Hermann; David Kozono; Edward Mannarino; Christina Molodowitch; Jon O Wee; David J Sher; Joseph H Killoran Journal: PLoS One Date: 2014-04-11 Impact factor: 3.240